Phase 1 Squamous Carcinoma Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Head and NeckHNSCCSquamous Cell Cancer of Head and Neck (SCCHN)+8 more
Vanderbilt-Ingram Cancer Center40 enrolled1 locationNCT07460765
Recruiting
Phase 1Phase 2
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Cervical CancerAnal CancerPenile Cancer+14 more
Christian Hinrichs15 enrolled2 locationsNCT05639972
Recruiting
Phase 1
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Colorectal, CancerHormone Receptor-Positive Breast CarcinomaGastric Adenocarcinoma+6 more
Avacta Life Sciences Ltd174 enrolled3 locationsNCT07454642
Recruiting
Phase 1Phase 2
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+1 more
Jonsson Comprehensive Cancer Center35 enrolled4 locationsNCT06543576
Recruiting
Phase 1
Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
Pancreatic CancerPancreatic AdenocarcinomaPancreatic Adenosquamous Carcinoma
Diakonos Oncology Corporation18 enrolled3 locationsNCT04157127